Q4 2024 · 13F-HR
Blue Water Life Science Advisors, LPholdings as filed
Filed 2025-02-13 · accession 0001420506-25-000379
$112.9M
Reported value
9
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 632307104 | NTRA | NATERA INC | $40.3M | 35.7% | 254,794 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $21.2M | 18.8% | 694,047 | Common | SOLE |
| 14167L103 | CDNA | CAREDX INC | $12.9M | 11.5% | 604,000 | Common | SOLE |
| 00650F109 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $12.9M | 11.4% | 2,145,145 | Common | SOLE |
| 00974H104 | — | AKOYA BIOSCIENCES INC | $10.8M | 9.53% | 4,697,785 | Common | SOLE |
| 71535D106 | PSNL | PERSONALIS INC | $6.5M | 5.80% | 1,132,900 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $4.4M | 3.92% | 78,843 | Common | SOLE |
| 88023B103 | TEM | TEMPUS AI INC | $3.0M | 2.69% | 90,000 | Common | SOLE |
| 74766Q101 | QTRX | QUANTERIX CORP | $833,318 | 0.74% | 78,393 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.